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From summary and commentary
This study examined the impact of Quality
and Outcomes Framework incentives on
rates of alcohol screening among people
with schizophrenia and other psychoses in
UK primary care.
The findings showed that financial rewards
corresponded with a substantial boost in
screening, particularly after the
introduction of the indicator for alcohol
consumption recording in 2011.
Almost all the records of alcohol
consumption complied with the Quality
and Outcomes Framework business rules,
ensuring that practices could be financially
reimbursed.
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 Impact of financial incentives on alcohol consumption recording in
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UK study of how Quality and Outcomes Framework incentives for primary care boosted alcohol
screening among patients with severe mental illness shows what could have happened had the
incentives been extended across the entire primary care caseload.
SUMMARY Though payment-for-performance schemes are widespread in the UK and USA, there
is mixed evidence about their impact on quality of care, and few evaluations considered to be
methodologically robust (1 2).
The Quality and Outcomes Framework was first
introduced in April 2004 to incentivise good
practice in primary care – providing financial
reward for achieving targets in the monitoring and
care of patients for different medical conditions. UK
primary care practices have been specifically
reimbursed for alcohol screening in people with
severe mental illness since April 2011.
The featured study aimed to determine the impact
of these financial incentives on alcohol screening in
England, Scotland, Wales and Northern Ireland, by
comparing rates of screening among people with
schizophrenia and other psychoses versus those
without between 2000 and 2013. A companion
study considered the impact of the Quality and
Outcomes Framework among people with bipolar
disorder.
Describing the recording of alcohol
consumption
A total of 14,860 people with diagnoses of
schizophrenia or other psychoses from 409 general practices were identified between April
2011–March 2013. All were aged 18–99 years old, and just over half were male (54%). The
mental health diagnoses were identified via ‘read codes’ (a standard vocabulary for clinicians to
record patient findings and procedures) in patients’ electronic primary care health records.
The researchers calculated the number of patients with a record of alcohol consumption. Rates
of recording of alcohol consumption between April 2011 and March 2013 were compared for men
versus women, different regions and socio-demographic groups, and for patients registered with
the practice within the past year versus those registered for longer.
Evaluating the impact of incentives over time
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To gauge the impact of Quality and Outcomes Framework incentives, the sample was expanded
to include people registered with the practices back to the year 2000, including periods when the
incentives were and were not in place. A separate cohort of people without a severe mental
illness was also randomly selected among those of the same sex, practice, and age band (18–
29, 30–49, 50–69, and 70–99 years).
The researchers compared the rates of alcohol consumption recording in people with
schizophrenia and other psychoses versus without across different time periods: 
• April 2000–March 2004 (before the severe mental illness Quality and Outcomes Framework); 
• April 2004–March 2006 (severe mental illness Quality and Outcomes Framework introduced); 
• April 2006–March 2011 (addition of lifestyle screening to the severe mental illness Quality and
Outcomes Framework indicators); 
• April 2011–March 2013 (addition of alcohol screening to the severe mental illness Quality and
Outcomes Framework indicators).
Main findings
Rates of alcohol consumption records varied considerably between general practices, ranging
from 42% to 100%. Around 21% of men and 10% of women with schizophrenia were recorded
as drinking at harmful or higher risk levels. Over three-quarters (78%) of people with
schizophrenia and other psychoses had an alcohol consumption record. In virtually all (99%) the
cases when drinking was recorded, the recording was eligible for remuneration under the Quality
and Outcomes Framework.
In 21% of cases more than one method was used to record alcohol consumption. When only one
method was used, it was most often a read code for level of alcohol consumed (52%), followed
by a record of units of alcohol in a week (27%). A very small number (0.33% or 38 cases)
recorded only a read code for type of screening test used.
The recording of alcohol consumption increased dramatically following the introduction of the
severe mental illness Quality and Outcomes Framework, with an 839% rise (more than eight-
fold increase) over the 13-year study period, compared with a 62% increase among people
without a severe mental illness. The most substantial rise occurred after the introduction of the
indicator for alcohol consumption recording in April 2011.
Alcohol consumption recording varied to a statistically significant degree by age, level of social
deprivation, and UK region. The highest levels of recording were observed among those aged
50–79 years old, those living in the most socially deprived areas, and those living in London.
The authors’ conclusions
The findings suggest that financial incentives provided through the severe mental illness Quality
and Outcomes Framework have had a substantial impact on alcohol consumption recording
among people with schizophrenia and other psychoses in primary care.
Almost all the records of alcohol consumption complied with the Quality and Outcomes
Framework business rules, ensuring that practices could be financially reimbursed. The same
was not true in a study of alcohol records among newly registered patients in UK primary care,
where the codes necessary for reimbursement under the Directed Enhanced Service were used
in only 9% of cases. The most plausible explanation for this finding was that the incentive
offered by the Directed Enhanced Service was substantially lower than that offered by the
Quality and Outcomes Framework (£2.38 per patient vs. £133.76 per point up to a maximum of
four in 2012/2013, respectively), and therefore had less influence on practitioner behaviour.
The Quality and Outcomes Framework has been criticised for incentivising recording practice,
rather than quality of care, which includes concerns that focusing on one patient group (such as
people with a severe mental illness) will result in detrimental effects on the quality of care for
non-targeted patients. This being said, the apparent impact on alcohol consumption screening
among patients with schizophrenia is an important finding given the high rates of harmful
drinking among these patients compared with the general population – 21% men and 10%
women with schizophrenia (2011–2013) vs. 1% men and 0.5% women newly registered with a
UK general practice (2007–2009). However, it is also important to note that under the Quality
and Outcomes Framework, practices could only be financially rewarded for the recording of
alcohol consumption among patients with severe mental illness not for any subsequent
treatment, which leads to uncertainty over the extent to which the framework supports patients
with schizophrenia to actually reduce their drinking.
Guidance from the National Institute for Health and Care Excellence (NICE) on the assessment
and management of a coexisting substance use issue and diagnosis of psychosis advocates the
referral of patients identified in primary care to secondary care mental health services for
assessment and further management. Psychosocial treatment is recommended for patients
drinking at harmful and dependent levels without a severe mental illness, but there is no
evidence that it works to reduce alcohol consumption or improve mental health in people with a
severe mental illness.
 
 COMMENTARY With the Quality and Outcomes Framework being the main way of
encouraging wider screening in primary care for priority public health issues, the featured results
have a broader significance. Going back to 2012, the UK alcohol strategy said the government
was awaiting the results of major English screening and brief intervention trials before deciding
whether to incorporate universal screening into the framework. The results subsequently offered
no support, and the framework continued to embrace smoking but not drinking. How much of a
difference including alcohol might have made can be gauged from the above study on patients
with schizophrenia and companion study on patients with bipolar disorder. The impacts noted
suggest that a similar boost to screening rates could have been expected across the entire
primary care caseload.
Compared to the year 2000, following introduction of the incentives, alcohol screening among
people with schizophrenia and other psychoses increased dramatically in primary health care
across the UK – an 839% rise. Among the remainder of the primary care caseload, the increase
was just 62%. In the incentives era drinking was recorded for 78% of the patients diagnosed
with schizophrenia or other psychosis seen at the general practices in the study, virtually all in
such a way that the record qualified the practice for the incentive payment. Per 1000 patients
per year, the proportion for whom drinking was recorded had been about the same for patients
with the relevant mental health diagnosis and those without, but for the former jumped after
2011 to reach 723 out of 1000 while it lagged at 184 among other patients. However, for just
588 (or 5%) of the 11,585 patients with schizophrenia or other psychosis in the study the
practice recorded the use of a screening test, raising concerns over the quality of the
identification of hazardous drinking.
The same research team observed a similar pattern among people with bipolar disorder. Over
the same time period, there was a nine-fold increase in recording of alcohol consumption in
primary care among people with bipolar disorder, compared with a more modest 57% increase
among people without severe mental illness. Between 2011–2013, over 80% of people with
bipolar disorder had their current alcohol levels recorded in primary care, with one fifth of
general practices attaining 100% recording levels. According to the authors: 
“While the concurrence of this rise in recording with the modification of [the Quality
and Outcomes Framework] to include alcohol screening does not prove that the rise
is a result of [the Quality and Outcomes Framework], the absence of alternative
likely influences, along with the observed relative stability of alcohol recording rates
in people without [severe mental illness], supports that the [Quality and Outcomes
Framework] for [severe mental illness] has played an important role”.
As previously stated, while payment-for-performance incentive schemes are widely used, there
is a lack of evidence about their impact on quality of care. A 2011 Cochrane review found
insufficient evidence to support or not support their use for this purpose. Six of the seven
studies identified showed positive but modest effects on a minority of the measures of quality of
care. Poor study design led to substantial risk of bias in most studies, and none of the studies
addressed issues of ‘selection bias’ – the ability of primary care doctors to select into or out of
the incentive scheme.
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